¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"propionate rule"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • astigmatism against the rule
    µµ³­½Ã, °Å²Ü³­½Ã
  • astigmatism with the rule
    Á÷³­½Ã, ¹Ù¸¥³­½Ã
  • interval rule
    °£°Ý±ÔÄ¢
  • multi-rule technique
    ´ÙÁß±ÔÄ¢±â¹ý
  • phase rule
    »óÀǹýÄ¢, »ó±ÔÄ¢
  • production rule
    »êÃâ¿øÄ¢
  • pairing rule
    ¦Áþ±â¿øÄ¢
  • rule
    1. ¹ýÄ¢, ±ÔÄ¢ 2. ¿øÄ¢
  • sum rule
    ÇÕÀǹýÄ¢
  • shunting rule
    Áö¸§±æ¹ýÄ¢
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • astigmatism with the rule
    Á÷³­½Ã, ¹Ù¸¥³­½Ã
  • astigmatism against the rule
    µµ³­½Ã, °Å²Ü³­½Ã
  • rule
    ¹ýÄ¢, ±ÔÄ¢, ¿øÄ¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • astigmatism against the rule
    µµ³­½Ã, °Å²Ü³­½Ã
  • astigmatism with the rule
    Á÷³­½Ã, ¹Ù¸¥³­½Ã
  • interval rule
    °£°Ý±ÔÄ¢
  • multi-rule technique
    ´ÙÁß±ÔÄ¢¹ý
  • pairing rule
    ¦Áþ±â¿øÄ¢
  • phase rule
    »óÀǹýÄ¢, »ó±ÔÄ¢
  • production rule
    »êÃâ¿øÄ¢
  • rule
    ¹ýÄ¢, ±ÔÄ¢, ¿øÄ¢
  • shunting rule
    Áö¸§±æ¹ýÄ¢
  • sum rule
    ÇÕÀDZÔÄ¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Knaps rule
    ³À¾¾¹ýÄ¢
  • MNaghten (=McNaughten) rule
    ¸Æ³ëư ±ÔÄ¢
  • McNaghten Rule
    ¸Æ³ëư±ÔÄ¢
  • Prentices rule
    ÇÁ·»Æ¼½º¹ýÄ¢
  • Prince rule
    ÇÁ¸°½º¹ýÄ¢
  • Westgard multi rule technique
    ¿þ½ºÆ®°¡µå´Ù¿ø±ÔÄ¢¹ý
  • against-the-rule astigmatism
    µµ³­½Ã
  • phase rule
    »ó·ü(ßÓëÏ).
  • production rule
    »êÃâ¿øÄ¢<--¹ýÄ¢>
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • desoxycorticosterone propionate
    ÇÁ·ÎÇÇ¿Â»ê µ¥¿Á½ÃÄÚ¸£Æ¼ÄÚ½ºÅ×·Ð.
  • testosterone propionate
    ÇÁ·ÎÇǿ»ê(¡­ß«)Å×½ºÅ佺Å×·Ð.
  • against-the-rule astigmatism
    µµ³­½Ã
  • astigmatism against-the-rule
    µµ³­½Ã(ÓîÕ¯ãÊ).
  • astigmatism with-the-rule
    Á÷³­½Ã.
  • interval rule
    °£°Ý±ÔÄ¢(¡­Ð®öÎ).
  • multi-rule technique
    ´Ù¹ýÄ¢<´Ù±ÔÄ¢>±â¹ý
  • pairing rule
    ¦Áþ±â¿øÄ¢.
  • phase rule
    »ó·ü(ßÓëÏ).
  • production rule
    »êÃâ¿øÄ¢<--¹ýÄ¢>
  • rule for substitution
    ġȯ±ÔÄ¢(öÇüµÐ®öÎ).
  • rule of nines
    9 ¹ýÄ¢
  • sum rule
    ÇÕÀÇ ±ÔÄ¢(ùꡭЮöÎ).
  • with-the-rule astigmatism
    Á÷³­½Ã
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • propionate rule
    ÇÁ·ÎÇǿ»ê(ß«) À²(ëÏ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Gibbs phase rule
    ±é½º À§»ó ¹ýÄ¢(êÈßÓÛööÎ)
  • GU-AG rule
    GU-AGÀ²(ëÏ)
  • Hudson's rule
    Çãµå½¼À²(ëÏ)
  • isoprene rule
    ¾ÆÀ̼ÒÇÁ·» À²(×È)
  • isorotation rule
    µî±¤È¸Àü À²(ÔõÎÃüÞï®ëÏ)
  • lactone rule
    ¶ôÅæ À²(ëÏ)
  • Landsteinter's rule
    ¶õÆ®½ºÅ¸Àε¥¸£À²(×È)
  • nitrogen rule
    Áú¼Ò·ü(òòáÈ×È)
  • phase rule
    »óÀ²(ßÓëÏ)
  • rule of mutual exclusion
    »óÈ£¹èÁ¦À²(ßÓû»ÛÉð¶ëÏ)
  • rule of the ring
    °í¸®À²(ëÏ)
  • Schuetz-Borrisow rule
    ½´Ã÷-º¸¸®¼Ò¿ì À²(ëÏ)
  • Traube's rule
    Æ®¶ó¿ìº£À²(ëÏ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RO radiation oncology; radiation output; ratio of; relative odds; renal osteodystrophy; reverse osmosis...
R/O rule out
CAP camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab...
DHTP dihydrotestosterone propionate
ECP ectrodactyly-cleft palate [syndrome]; effector cell precursor; endocardial potential; eosinophil cat...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NPRM Notice of Proposed Rule Making
ATR against the rule
WTR with the rule
FP Fluticasone Propionate
FPANS Fluticasone Propionate Aqueous Nasal Spray
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • calcium propionate
    ÇÁ·ÎÇǿ »ê Ä®½·
    ÇÁ·ÎÇǿ »êÀÇ Ä®½·¿°. Ç× Áø±Õ¼ºÀ» °®´Â´Ù. ´Üµ¶À¸·Î ¶Ç´Â ÇÁ·ÎÇǿ »ê ³ªÆ®·ýÀ̳ª ´Ù¸¥ ¿ä¼Ò¿Í °áÇÕÇÏ¿© ¹æºÎÁ¦¿Í ±¹¼ÒÀû Ç× Áø±ÕÁ¦·Î »ç¿ëµÈ´Ù.
  • astigmatism against-the-rule
    µµ³­½Ã
  • basic rule
    ±âº» ¿øÄ¢
  • Jackson's rule
    Àè½¼ ¹ýÄ¢
    °£Áú ¹ßÀÛ ÈÄ ´Ü¼øÇÑ ±â´ÉÀº º¹ÀâÇÑ ±â´Éº¸´Ù »¡¸® ȸº¹ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
calcium propionate The calcium salt of propionic acid; an antifungal agent.
(05 Mar 2000)
clobetasol propionate Pregna-1,4-diene-3,20-dione,21-chloro-9-fluoro-11-hyroxy-16-methyl-17-(1-oxopropoxy)-,(11b,16b)-;an anti-inflammatory corticosteroid usually used in topical preparations.
(05 Mar 2000)
propionate <chemistry> A salt of propionic acid.
Source: Websters Dictionary
(01 Mar 1998)
propionate-3-nitronate oxidase <enzyme> From penicillium atrovenetum; flavoprotein; catalyses the oxidation of propionate 3-nitronate in the presence of oxygen to yield malonate saemialdehyde, no2, no3 and h2o2
Registry number: EC 1.7.3.-
Synonym: 3-nitropropionate oxidase
(26 Jun 1999)
sodium propionate The sodium salt of propionic acid; used for fungus infections of the skin, usually in combination with calcium propionate; used as a preservative.
(05 Mar 2000)
succinyl CoA propionate CoA-transferase <enzyme> Succinyl CoA and propionate gives propionyl CoA and succinate
Registry number: EC 2.8.3.-
Synonym: succinyl coenzyme a propionate coenzyme a-transferase
(26 Jun 1999)
dromostanolone propionate 17b-Hydroxy-2a-methyl-5a-androstan-3-one propionate;an antineoplastic agent.
(05 Mar 2000)
testosterone propionate <drug> A preparation that has an action similar to but more pronounced and prolonged than that of testosterone; used in the treatment of undescended testes and in menorrhagia.
(05 Mar 2000)
erythromycin propionate A salt of the macrolide antibiotic, erythromycin.
(05 Mar 2000)
3-(3-hydroxyphenyl)propionate hydroxylase <enzyme> Isolated from rhodococcus globerulus; has been sequenced; genbank u89712
Registry number: EC 1.14.-
Synonym: 3hpp hydroxylase, hppa gene product (hydroxylase)
(26 Jun 1999)
4-imidazolone-5-propionate An intermediate in histidine degradation; seen in reduced levels in urocanic aciduria.
(05 Mar 2000)
Abegg's rule The tendency of the sum of the maximum positive and maximum negative valence of a particular element to equal 8; e.g., C may have a valence of +4 and -4, O of +6 and -2. Sometimes loosely stated as all atoms have the same number of valences, a consequence of the tendency of valence electron shells to be filled to 8.
(05 Mar 2000)
American Law Institute rule A test of criminal responsibility (1962): "a person is not responsible for criminal conduct if at the time of such conduct as a result of mental disease or defect he lacks substantial capacity either to appreciate the wrongfulness of his conduct or to conform his conduct to the requirements of law."
(05 Mar 2000)
astigmatism against the rule Astigmatism when the greater curvature or refractive power is in the horizontal meridian.
(05 Mar 2000)
astigmatism with the rule Astigmatism when the greater curvature or refractive power is in the vertical meridian.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • rule
    ±ÔÄ¢,Áö¹è,¸í·É,Áö¹èÇÏ´Ù,ÅëÄ¡ÇÏ´Ù
  • rule of thumb
    °æÇè¿¡¼­ ¾òÀº ¹ýÄ¢
  • rule out
    ¹èÁ¦ÇÏ´Ù
  • Dillon's Rule
    (¹Ì¹ý)µô·ÐÀÇ ¿øÄ¢(Áö¹æ ÀÚġüÀÇ ±ÇÇÑÀº ÁÖÇå¹ý ¶Ç´Â ¹ý¿¡ ¸í±âµÈ °Í¿¡ ÇÑÇÑ´Ù´Â ¿øÄ¢)
  • Miranda rule
    (¹Ì)¹Ì·£´õ ÁØÄ¢(¿øÄ¢)(À§¹ý ¼öÁý Áõ°Å ¹èÁ¦ ¿øÄ¢)
  • Rozelle rule
    ·ÎÁ© ±Ô¾à(ÇÁ·Î ¸®±×¿¡¼­ÀÇ ¼±¼ö °è¾à ±ÔÄ¢ÀÇ Çϳª)
  • Rule,Britannia
    ºê¸®ÅÂÀ̾;ÅëÄ¡Ç϶ó(¿µ±¹ÀÇ ±¹°¡)
  • caliper rule
    ͏®ÆÛ½º ÀÚ
  • chain rule
    ¿¬¼â ¹ýÄ¢
  • civilian rule
    ¹ÎÁ¤
  • exclusionary rule
    (¹Ì¹ý)(À§¹ý ¼öÁý Áõ°Å)¹èÁ¦ÀÇ ¿øÄ¢
  • foot rule
    ÇÇÆ®ÀÚ
  • gag rule
    (¾î¶² ¹®Á¦¿¡ ´ëÇÑ)Åä·Ð ±ÝÁö·É;ÇÔ±¸·É
  • general rule
    ÃÑÄ¢
  • golden rule
    Ȳ±Ý·ü(¸¶Åº¹À½ÀÇ »ê»ó¼öÈÆ ÁßÀÇ ¸»,"¹«¾ùÀ̵çÁö ³²¿¡°Ô ´ëÁ¢À» ¹Þ°íÀÚ ÇÏ´Â ´ë·Î ³ÊÈñµµ ³²À» ´ëÁ¢Ç϶ó")
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á